MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Vial comparison
Compare Survodutide listings by strength, selection and supplier. Inspect the original source behind each price.
MATCH SIZE AND QUANTITY
Choose a labeled amount and selection to load matching prices.
GO BEYOND THE PRICE
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Reported quantities in this family: 1. Counts and units must be matched to the exact listing.
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. 1 listing in this family have incomplete quantity details and receive no inferred per-mg price.
Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.
| Strength | Selection | Lowest listed total price | Price per mg | Supplier count | Compare |
|---|---|---|---|---|---|
| 6 mg | 1 vial | $225.00 | $37.50 | 1 | Compare |
| 10 mg | 1 vial | $48.99 | $4.90 | 7 | Compare |

153 products · 275 listings

36 products · 58 listings

34 products · 51 listings

44 products · 62 listings

19 products · 25 listings

35 products · 40 listings
34 products · 47 listings

41 products · 52 listings

50 products · 65 listings
1 listing from direct supplier captures and 8 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
FROM PEPTIDES CALCULATOR
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
Survodutide (BI 456906) is an investigational once-weekly injectable peptide from Boehringer Ingelheim, licensed from Zealand Pharma, that activates both the glucagon receptor and the GLP-1 receptor. It is a 29-amino-acid analog of human glucagon with a protease-resistant residue at position 2 and a C18 fatty diacid on a linker at position 24 that binds albumin and stretches its half-life to allow weekly dosing. Phase 2 trials reported up to 14.9% weight loss at 46 weeks in obesity and histological improvement of MASH at 48 weeks, and the phase 3 SYNCHRONIZE-1 and SYNCHRONIZE-2 trials published in 2026 reported 16.6% and 13.1% weight loss at 76 weeks among participants who stayed on treatment (13.0% in SYNCHRONIZE-1 once dropouts are counted). It has no approved label anywhere, so every schedule below is a trial protocol or a community copy of one, and vials sold online as survodutide are unregulated research chemicals.
Research indicates that Survodutide works by binding to specific receptors in the brain and other tissues, which are involved in regulating hunger and energy expenditure.…
The therapeutic potential of Survodutide lies in its ability to modulate key metabolic pathways. By mimicking the action of natural hormones, Survodutide can regulate appetite, enhance satiety, and promote weight loss.…
Preclinical Studies Preclinical studies on Survodutide have provided promising insights into its potential benefits. In various animal models, Survodutide has been shown to significantly reduce body weight, regulate appetite, and improve metabolic health.…
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.